This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
PRAC recommendations on signals adopted at the 10-13 February 2025 meeting
Human medicines European public assessment report (EPAR): Revinty Ellipta, fluti...
Template for late submission of ICSRs to EV
PhV non-compliance notification contact points at National Competent Authority (...
Veterinary medicines European public assessment report (EPAR): Prevexxion RN, Ma...
Human medicines European public assessment report (EPAR): Koselugo, selumetinib,...
Human medicines European public assessment report (EPAR): Rozlytrek, entrectinib...
Veterinary medicines European public assessment report (EPAR): Mhyosphere PCV ID...
Human medicines European public assessment report (EPAR): mResvia, Single-strand...
Veterinary medicines European public assessment report (EPAR): Porcilis PCV, adj...
Scientific advice under Article 115(5) of Regulation (EU) 2019/6 on veterinary m...
Human medicines European public assessment report (EPAR): Dimethyl fumarate Acco...
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 1...
Human medicines European public assessment report (EPAR): Yesafili, aflibercept,...
First vaccine against epizootic haemorrhagic disease recommended for approval
Summary of opinion: Rheumocam, 13/03/2025 Positive
Veterinary medicines European public assessment report (EPAR): Prevestrus vet, f...
Veterinary medicines European public assessment report (EPAR): Prazivetin, prazi...
Veterinary medicines European public assessment report (EPAR): Hepizovac, epizoo...
Veterinary medicines European public assessment report (EPAR): Nobilis Multriva ...